Treatments:Cancer
From Proteopedia
(Difference between revisions)
| Line 4: | Line 4: | ||
=====Anti-CD20 [[Monoclonal Antibody]]===== | =====Anti-CD20 [[Monoclonal Antibody]]===== | ||
* [[Arzerra]] - Generic: Ofatumumab | * [[Arzerra]] - Generic: Ofatumumab | ||
| - | * Rituxan - Generic: Rituximab | + | * [[Rituxan]] - Generic: Rituximab |
=====[[Epidermal Growth Factor Receptor]] Inhibitor===== | =====[[Epidermal Growth Factor Receptor]] Inhibitor===== | ||
* [[Herceptin]] - Generic: Trastuzumab | * [[Herceptin]] - Generic: Trastuzumab | ||
Revision as of 10:27, 14 December 2010
Anti-CD20 Monoclonal AntibodyEpidermal Growth Factor Receptor Inhibitor
Estrogen Receptor Modulator
Multiple Receptor Tyrosine Kinase (VEGFR, PDGFR, EGFR, KIT, Abl) Inhibitor
Vascular Endothelial Growth Factor Inhibitor
|
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Michal Harel, Alexander Berchansky, Karsten Theis
